FDA Drug Approvals Monitor
47
April 2026
Regulatory
New drug and biologic approvals granted by the US Food and Drug Administration each month, structured from FDA press announcements, CDER updates, and pharmaceutical news. Each record covers the drug or therapy name, the pharmaceutical company receiving approval, the approved indication, approval pathway (standard, priority review, breakthrough therapy, accelerated approval), and the approval date. FDA supplemental approvals for significant new indications are included alongside new molecular entity approvals.
FDA drug approvals regulatory decisions April 2026
Pharmaceutical investors and biotech analysts use it to monitor competitive approvals and track pipeline-to-market conversion rates. Healthcare providers and formulary teams identify newly approved treatment options through it. Medical affairs and market access teams at pharma companies benchmark approval timelines. Financial journalists covering the biopharma sector use it to report on regulatory milestones.
44000
<table class="catchall-table"><th style="min-width:180px"><tr><th>Drug / Decision</th><th style="min-width:300px">Description</th><th style="min-width:120px;white-space:nowrap">Date</th><th style="min-width:180px">Therapeutic Area</th><th style="min-width:120px;white-space:nowrap">Source</th></tr></thead><tbody><tr><td style="min-width:180px">Leqembi (lecanemab) label update</td><td style="min-width:300px">FDA approves expanded label for early Alzheimer treatment</td><td style="white-space:nowrap">Apr 2, 2026</td><td style="min-width:180px">Neurology</td><td style="white-space:nowrap">fda.gov</td></tr><tr><td style="min-width:180px">Keytruda new indication</td><td style="min-width:300px">Pembrolizumab approved for resectable NSCLC adjuvant therapy</td><td style="white-space:nowrap">Apr 5, 2026</td><td style="min-width:180px">Oncology</td><td style="white-space:nowrap">merck.com</td></tr><tr><td style="min-width:180px">Zepbound obesity expanded approval</td><td style="min-width:300px">Tirzepatide approved for obesity-related cardiovascular risk reduction</td><td style="white-space:nowrap">Apr 9, 2026</td><td style="min-width:180px">Metabolic / Cardiovascular</td><td style="white-space:nowrap">lilly.com</td></tr><tr><td style="min-width:180px">Dupixent asthma paediatric</td><td style="min-width:300px">Dupilumab approved for children aged 1-11 with moderate-to-severe asthma</td><td style="white-space:nowrap">Apr 12, 2026</td><td style="min-width:180px">Immunology</td><td style="white-space:nowrap">sanofi.com</td></tr><tr><td style="min-width:180px">CAR-T cell therapy approval</td><td style="min-width:300px">Breakthrough therapy for relapsed/refractory multiple myeloma</td><td style="white-space:nowrap">Apr 16, 2026</td><td style="min-width:180px">Haematology</td><td style="white-space:nowrap">fda.gov</td></tr><tr class="catchall-blurred"><td>████████████</td><td>████████████████████</td><td>Apr 18, 2026</td><td>████████</td><td>████████</td></tr><tr class="catchall-blurred"><td>████████████</td><td>████████████████████</td><td>Apr 20, 2026</td><td>████████</td><td>████████</td></tr><tr class="catchall-blurred"><td>████████████</td><td>████████████████████</td><td>Apr 22, 2026</td><td>████████</td><td>████████</td></tr></tbody></table>
<h3>Does this include both NME approvals and supplemental approvals for new indications?</h3><p>New molecular entity (NME) and biologics license application (BLA) approvals are the primary focus. Supplemental approvals are included where they represent a significant new treatment option.</p><h3>How does this differ from Drugs@FDA?</h3><p>Drugs@FDA is comprehensive but not structured for bulk analysis. CatchAll extracts the same FDA announcements and structures them with enriched fields – indication category, approval pathway, company, and date – making them easier to filter programmatically.</p><h3>Is May 2026 data available?</h3><p>Yes. The FDA and EMA combined approvals page covers May 2026 and includes EMA approvals alongside FDA.</p><h3>What is the refresh rate of this dataset?</h3><p>We rerun this dataset once a month. You can create your own dataset that updates as frequently as every one hour on <a href="https://platform.newscatcherapi.com/catchall">platform.newscatcherapi.com/catchall</a></p>